Cargando…
The Impact of the GOLD 2023 on Clinical Treatment in Northeast China
Autores principales: | Zhou, Jiawei, Li, Xiaomeng, Li, Xiang, Wang, Na, Cai, Xu, Zhang, Lei, Li, Chen, Wang, Wei, Yu, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695018/ http://dx.doi.org/10.2147/COPD.S418971 |
Ejemplares similares
-
Tip of the iceberg: species diversity of Pholcus spiders (Araneae, Pholcidae) in the Changbai Mountains, Northeast China
por: Yao, Zhi-Yuan, et al.
Publicado: (2021) -
The Construction of Primary Screening Model and Discriminant Model for Chronic Obstructive Pulmonary Disease in Northeast China
por: Li, Xiaomeng, et al.
Publicado: (2020) -
GOLD 2023 Update: Implications for Clinical Practice
por: Tamondong-Lachica, Diana R, et al.
Publicado: (2023) -
Accuracy of Six Chronic Obstructive Pulmonary Disease Screening Questionnaires in the Chinese Population
por: Zhou, Jiawei, et al.
Publicado: (2022) -
Development of clinical trials for non-small cell lung cancer drugs in China from 2005 to 2023
por: Jia, Wanying, et al.
Publicado: (2023)